92 results
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
8 May 24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
8:35am
this new JDA will be led at Cleveland Clinic by Thaddeus Stappenbeck, MD, PhD, Department Chair of Inflammation and Immunity, and will include Justin
S-8
ANIX
Anixa Biosciences Inc
16 Jan 24
Registration of securities for employees
4:43pm
. Department of Defense grant to Cleveland Clinic, is a multiple-ascending dose Phase 1 trial to determine the maximum tolerated dose (“MTD”) of the vaccine
8-K
EX-99.1
vha965nij694ishq nq
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
EX-99.1
h87o4i
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
84idjdhl3s jjtrthi
29 Sep 22
Regulation FD Disclosure
8:30am
S-8
h6pkzb2j 6xi2m22
4 Jan 22
Registration of securities for employees
4:12pm
8-K
z4pi49ur
28 Oct 21
Regulation FD Disclosure
4:54pm
8-K
xu6h1flbp164sm
4 Oct 21
Other Events
7:00am